In the year 2021, the primary market gained strong traction and around 63 companies picked up 1.2 lakh crore through Initial Public Offering (IPO). Several newly listed stocks have seen improvement, among them brokerage house Religare Broking has shortlisted 5 stocks which they believe have good long-term growth potential.
Clean Science & Technology: “The company is well positioned in both the Indian and global markets. Going forward, its risk-free business model, leadership position and expansion across various products will drive growth. On the financial front, the company is debt free. And his performance over the years has been encouraging.” The brokerage’s buy rating on a particular chemical stock comes with a target price 2,509.
Data Pattern (India): Religare has a positive outlook on the company for the long term and has assigned a buy rating on the stock with a target price. 842 per share.
Heramba Industries: According to the brokerage, given its expertise in agrochemicals, a wide distribution network, strong manufacturing capability and expansion plans augur well for future growth. its target value is 832 on the newly listed stock.
Latent View Analytics: “Going forward, the company’s strategy is to work towards innovation, growing geographic presence and expanding through inorganic growth opportunities. We have assigned a buy rating with a target price of 532.”
MedPlus Health Services: Religare said going forward, the company intends to grow its omnichannel platform with a hyper-local delivery model, foray into new geographies and increase the share of private labels which will aid in revenue growth. The brokerage has a target price 1,215 each on MedPlus shares.
The views and recommendations given above are those of individual analysts or broking companies and not of Mint.
download
The app will get 14 days of unlimited access to Mint Premium absolutely free!